FDA Inspection
Hubei Haosun Pharmaceutical Co., Ltd.Hubei Haosun Pharmaceutical Co., Ltd. – FDA Inspection, Sep 2, 2016
Record Details
This FDA Inspection record concerns Hubei Haosun Pharmaceutical Co., Ltd., with an inspection on September 2, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 2, 2016
- Product Type
- Drugs
View Company Profile
ID · 2ce1f1f8-37cd-4112-9b2b-ac1dfaca97f6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 988662
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Hubei Haosun Pharmaceutical Co., Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2025 | Not classified | Office of Inspections and Investigations | |
| March 9, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 15, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 16, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hubei Haosun Pharmaceutical Co., Ltd.
- FDA Inspection 1280335 - 2025-08-01
- FDA Inspection 1047621 - 2018-03-09
- FDA Inspection 867397 - 2013-11-15
- FDA Inspection 738545 - 2011-07-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.